| Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States R Houghton, RC Ong, F Bolognani Autism Research 10 (12), 2037-2047, 2017 | 119 | 2017 |
| Treatment patterns in children with autism in the United States BU Monz, R Houghton, K Law, G Loss Autism Research 12 (3), 517-526, 2019 | 99 | 2019 |
| Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions CL Freeman, F Morschhauser, L Sehn, M Dixon, R Houghton, T Lamy, ... Blood, The Journal of the American Society of Hematology 126 (24), 2646-2649, 2015 | 79 | 2015 |
| Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... Science translational medicine 12 (574), eabc2888, 2020 | 72 | 2020 |
| Psychiatric comorbidities and psychotropic medication use in autism: a matched cohort study with ADHD and general population comparator groups in the United Kingdom R Houghton, C Liu, F Bolognani Autism Research 11 (12), 1690-1700, 2018 | 34 | 2018 |
| Psychometric validation of the autism impact measure (AIM) R Houghton, B Monz, K Law, G Loss, S Le Scouiller, F de Vries, ... Journal of autism and developmental disorders 49, 2559-2570, 2019 | 22 | 2019 |
| Psychometric Validation of the Autism Impact Measure (AIM)(vol 49, pg 2559, 2019) R Houghton, B Monz, K Law, G Loss, S Le Scouiller, F de Vries, ... JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS 49 (6), 2571-2571, 2019 | 22* | 2019 |
| Modeling manifest Huntington’s disease prevalence using diagnosed incidence and survival time V Crowell, R Houghton, A Tomar, T Fernandes, F Squitieri Neuroepidemiology 55 (5), 361-368, 2021 | 21 | 2021 |
| Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab CL Freeman, M Dixon, R Houghton, KA Kreuzer, G Fingerle-Rowson, ... Leukemia 30 (8), 1763-1766, 2016 | 21 | 2016 |
| Psychostimulants/atomoxetine and serious cardiovascular events in children with ADHD or autism spectrum disorder R Houghton, F De Vries, G Loss CNS drugs 34, 93-101, 2020 | 17 | 2020 |
| Comorbidity trajectories associated with Alzheimer’s disease: a matched case-control study in a United States claims database LM Butler, R Houghton, A Abraham, M Vassilaki, G Durán-Pacheco Frontiers in neuroscience 15, 749305, 2021 | 13 | 2021 |
| Pattern of cytokine release in patients with chronic lymphocytic leukemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR) CL Freeman, F Morschhauser, LH Sehn, M Dixon, R Houghton, T Lamy, ... Blood 124 (21), 4674, 2014 | 13 | 2014 |
| Risk factors associated with the development of infusion-related reactions in patients with chronic lymphocytic leukaemia treated with anti-CD20 monoclonal antibodies: analysis … CL Freeman, M Dixon, R Houghton, K Humphrey, G Fingerle-Rowson, ... Blood 124 (21), 3339, 2014 | 12 | 2014 |
| Treatment patterns in patients with incident Parkinson’s disease in the United States R Houghton, F Boess, L Verselis, Y Ding, R Freitas, N Constantinovici, ... Journal of Parkinson's Disease 9 (4), 749-759, 2019 | 11 | 2019 |
| Ranking the predictive power of clinical and biological features associated with disease progression in Huntington's disease N Ghazaleh, R Houghton, G Palermo, SA Schobel, PA Wijeratne, JD Long Frontiers in neurology 12, 678484, 2021 | 8 | 2021 |
| Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders R Houghton, J van den Bergh, K Law, Y Liu, F de Vries Autism Research 14 (8), 1800-1814, 2021 | 7 | 2021 |
| Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: The prospective HD-CSF study FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... medRxiv, 2020.03. 31.20045260, 2020 | 7 | 2020 |
| Comorbidities and clinical outcomes in adult-and juvenile-onset Huntington’s disease: a study of linked Swedish National Registries (2002–2019) H Furby, S Moore, AL Nordstroem, R Houghton, D Lambrelli, S Graham, ... Journal of Neurology 270 (2), 864-876, 2023 | 3 | 2023 |
| Utilisation and outcomes of treatment in Autism Spectrum Disorder R Houghton | 1 | 2021 |
| Discovering Dominant Features Associated with Disease Progression in Huntington’s Disease (HD): A Data-driven Approach Using the Enroll-HD Database (1603) N Ghazaleh, R Houghton, G Palermo, SA Schobel, P Wijeratne, J Long Neurology 94 (15 Supplement), 2020 | 1 | 2020 |
